A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease Who Have Lost Response or Are Intolerant to Infliximab
收藏DataCite Commons2025-07-24 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002963/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and either lost response or discontinued its use as a result of intolerance to the drug.
提供机构：
Vivli
创建时间：
2018-10-27
